One in five (19%) firms over 200 workers covers GLP-1 agonists for weight loss with more coverage among larger firms One-in-five (19%) firms with 200 or more workers, including 43% of firms with 5,000 or more workers, cover GLP-1 drugs for weight loss in their largest health plan in 2025
La eleccin no debera basarse en cul parece ms potente, sino en la dosificacin, la comodidad y el coste real
[1] [4] There is insufficient evidence regarding the safety of glutathione injection in pregnancy and lactation, and its use in these populations should be avoided unless the potential benefits outweigh the risks
In the case of the secret shopper study, 60% of the pharmacies added a supplement to the GLP-1 (B12 and glycine were most common)
Rapid weight loss is contributing to hollowing in the cheeks, under-eye depressions, laxity along the jawline and neck, and an overall decline in skin quality: what the internet now calls Ozempic Face. This is where aesthetic providers can play an important role, offering customized laser and light-based treatment for Ozempic face that helps patients feel like themselves again while supporting their weight-loss journey